Vaxxinity, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VAXX research report →
About the company
Vaxxinity, Inc. , a biotechnology company founded in 2014 and headquartered in Dallas, Texas, is dedicated to advancing novel therapeutic candidates for human application in the United States. Its primary areas of focus are neurological disorders and infectious diseases, particularly those caused by coronaviruses.
- CEO
- Mei Mei Hu
- IPO
- 2021
- Employees
- 57
- HQ
- Dallas, TX, US
Price Chart
- Market Cap
- $2.12M
- P/E
- -33.50
- P/S
- 0.00
- P/B
- 0.16
- EV/EBITDA
- -0.23
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -0.15%
- ROIC
- -203.71%
- Revenue
- $0 · 0.00%
- Net Income
- $-56,934 · 99.92%
- EPS
- $-0.00 · 99.92%
- Op Income
- $-58,285,000
- FCF YoY
- -0.43%
- 52W High
- $0.20
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 3.78
- Avg Volume
- 12.78K
Get TickerSpark's AI analysis on VAXX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 1, 23 | Ray Sumita | other | 425,000 |
| Nov 3, 23 | Paula Molina Rene | other | 0 |
| Oct 2, 23 | Powchik Peter | other | 159,744 |
| Oct 1, 23 | Ray Sumita | other | 0 |
| Sep 6, 23 | Prime Movers Lab Fund I LP | sell | 5,308 |
| Sep 7, 23 | Prime Movers Lab Fund I LP | sell | 20,312 |
| Sep 8, 23 | Prime Movers Lab Fund I LP | sell | 25,089 |
| Sep 6, 23 | Prime Movers Lab Fund I LP | sell | 2,189 |
| Sep 7, 23 | Prime Movers Lab Fund I LP | sell | 8,378 |
| Sep 8, 23 | Prime Movers Lab Fund I LP | sell | 10,349 |
Our VAXX coverage
Recent articles, reports, and earnings notes.
No research on VAXX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VAXX report →Similar companies
Peers in the same neighborhood.